These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15962532)

  • 21. Declining invasive pneumococcal disease in the U.S. elderly.
    McBean AM; Park YT; Caldwell D; Yu X
    Vaccine; 2005 Dec; 23(48-49):5641-5. PubMed ID: 16111788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of invasive pneumococcal disease after introduction of the Universal Infant Immunization Program, British Columbia (2002-2005).
    Can Commun Dis Rep; 2006 Jul; 32(14):157-61. PubMed ID: 16869067
    [No Abstract]   [Full Text] [Related]  

  • 25. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization coverage against invasive pneumococcal disease among children in the Capital Health Region of Alberta.
    Can Commun Dis Rep; 2005 Mar; 31(6):65-8. PubMed ID: 15875323
    [No Abstract]   [Full Text] [Related]  

  • 27. Universal pneumococcal vaccination for India.
    Mathew JL
    Indian Pediatr; 2008 Feb; 45(2):160-1. PubMed ID: 18310801
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase in invasive pneumococcal disease in children associated with shortage of heptavalent pneumococcal conjugate vaccine.
    Abuelreish M; Subedar A; Chiu T; Wludyka P; Rathore M
    Clin Pediatr (Phila); 2007 Jan; 46(1):45-52. PubMed ID: 17164509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumonia vaccine protocol could save money and lives.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(5):5-7. PubMed ID: 12440407
    [No Abstract]   [Full Text] [Related]  

  • 30. Introduction of a new vaccine in EPI; what we can achieve from a programme in failure.
    Tanzil S; Jamali T; Rizvi N
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):702. PubMed ID: 25233984
    [No Abstract]   [Full Text] [Related]  

  • 31. Adults with invasive pneumococcal disease: missed opportunities for vaccination.
    Kyaw MH; Greene CM; Schaffner W; Ray SM; Shapiro M; Barrett NL; Gershman K; Craig AS; Roberson A; Zell ER; Schuchat A; Bennett NM; Whitney CG;
    Am J Prev Med; 2006 Oct; 31(4):286-92. PubMed ID: 16979452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pneumococcal preventive vaccination. Consensus report, 3].
    Ambrosch F; Francesconi M; Graf H; Huber W; Kollaritsch H; Kunze M; Maurer G; Popp W; Prior C; Sertl K; Slany J; Wiedermann G
    Wien Med Wochenschr; 1998; 148(8-9):203. PubMed ID: 9677677
    [No Abstract]   [Full Text] [Related]  

  • 33. [The future of the chickenpox vaccine program].
    Trudeau G
    Perspect Infirm; 2006; 3(3):31-2. PubMed ID: 16480056
    [No Abstract]   [Full Text] [Related]  

  • 34. [Organizational models of vaccine practices].
    Valsecchi M; Napoletano G; Nguyen T; Zivelonghi G
    Ann Ig; 2002; 14(3 Suppl 3):75-82. PubMed ID: 12389414
    [No Abstract]   [Full Text] [Related]  

  • 35. Publicly-funded influenza and pneumococcal immunization programs in Canada: a progress report.
    Squires SG; Pelletier L
    Can Commun Dis Rep; 2000 Sep; 26(17):141-8. PubMed ID: 11008402
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A; Patel N; Scott DA; Runge C; Claes C; Rose M
    Eur J Health Econ; 2008 Feb; 9(1):7-15. PubMed ID: 17333089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From the Centers for Disease Control and Prevention. Increasing pneumococcal vaccination rates among patients of a national health-care alliance--United States, 1993.
    JAMA; 1995 Nov; 274(17):1333-4. PubMed ID: 7563545
    [No Abstract]   [Full Text] [Related]  

  • 38. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine.
    Silfverdal SA; Berg S; Hemlin C; Jokinen I
    Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine preventable diseases and vaccination policy for indigenous populations.
    Menzies RI; Singleton RJ
    Pediatr Clin North Am; 2009 Dec; 56(6):1263-83. PubMed ID: 19962021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seven-valent pneumococcal conjugate vaccines for developing countries.
    Obaro S
    Expert Rev Vaccines; 2009 Aug; 8(8):1051-61. PubMed ID: 19627187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.